Cytogen, Inc. (KOSDAQ: 217330)
6,820.00
+50.00 (0.74%)
Sep 11, 2024, 2:52 PM KST
Cytogen Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 27,083 | 54,838 | 15,878 | 30,288 |
Short-Term Investments | 22,053 | 49.46 | 50.43 | 5,515 |
Trading Asset Securities | 3,057 | - | 1,993 | - |
Cash & Short-Term Investments | 52,193 | 54,887 | 17,922 | 35,803 |
Cash Growth | 494.57% | 206.26% | -49.94% | - |
Accounts Receivable | 1,053 | 473.96 | 588.23 | 88.9 |
Other Receivables | 715.86 | 259.88 | 164.15 | 137.48 |
Receivables | 1,769 | 733.84 | 752.38 | 226.38 |
Inventory | 207.05 | 25.3 | 131.47 | - |
Prepaid Expenses | 200.7 | 234.71 | 186.73 | 73.13 |
Other Current Assets | 1,372 | 122.29 | 396.76 | 7,487 |
Total Current Assets | 55,742 | 56,003 | 19,389 | 43,589 |
Property, Plant & Equipment | 5,205 | 4,980 | 3,104 | 2,808 |
Long-Term Investments | 5,527 | 5,527 | 7,331 | 7,321 |
Goodwill | 2,933 | 2,723 | 5,712 | - |
Other Intangible Assets | 4,985 | 4,830 | 5,310 | 1,496 |
Other Long-Term Assets | 1,214 | 386.96 | 375.1 | 313.75 |
Total Assets | 75,606 | 74,450 | 41,220 | 55,528 |
Accounts Payable | 738.09 | 206.64 | 189.2 | 112.63 |
Accrued Expenses | 613.28 | 730.43 | 1,006 | 376.4 |
Short-Term Debt | 297.62 | 7,980 | 25,758 | 3,280 |
Current Portion of Leases | 624.79 | 556.4 | 474.98 | 442.66 |
Other Current Liabilities | 952.14 | 1,274 | 6,502 | 2,579 |
Total Current Liabilities | 3,226 | 10,747 | 33,930 | 6,791 |
Long-Term Debt | 12,299 | 8,371 | - | 20,445 |
Long-Term Leases | 428.13 | 669.13 | 191.3 | 456.46 |
Long-Term Deferred Tax Liabilities | 568.86 | 549.23 | 838.98 | - |
Other Long-Term Liabilities | 4,305 | 721.58 | 551.38 | 4,635 |
Total Liabilities | 21,039 | 21,095 | 35,564 | 32,519 |
Common Stock | 11,212 | 11,139 | 8,934 | 2,947 |
Additional Paid-In Capital | 113,139 | 107,523 | 50,759 | 54,635 |
Retained Earnings | -73,962 | -68,072 | -52,302 | -33,531 |
Treasury Stock | -3,234 | -3,234 | -3,234 | -3,234 |
Comprensive Income & Other | 7,412 | 5,998 | 1,500 | 2,192 |
Shareholders' Equity | 54,566 | 53,355 | 5,656 | 23,009 |
Total Liabilities & Equity | 75,606 | 74,450 | 41,220 | 55,528 |
Total Debt | 13,650 | 17,576 | 26,424 | 24,624 |
Net Cash (Debt) | 38,543 | 37,311 | -8,502 | 11,179 |
Net Cash Per Share | 1878.92 | 2040.21 | -481.37 | 659.73 |
Filing Date Shares Outstanding | 22.36 | 22.22 | 17.81 | 17.5 |
Total Common Shares Outstanding | 22.36 | 22.22 | 17.81 | 17.5 |
Working Capital | 52,516 | 45,256 | -14,541 | 36,798 |
Book Value Per Share | 2440.02 | 2401.36 | 317.61 | 1314.64 |
Tangible Book Value | 46,649 | 45,803 | -5,365 | 21,513 |
Tangible Book Value Per Share | 2085.96 | 2061.45 | -301.26 | 1229.19 |
Land | 277.84 | 257.88 | - | - |
Buildings | 2,125 | 1,973 | - | - |
Machinery | 900.46 | 852.03 | 969.67 | 432.63 |
Construction In Progress | 227.78 | 14 | 65.06 | 507.95 |
Source: S&P Capital IQ. Standard template. Financial Sources.